CHINA SXT PHARMACEUTICALS IN (SXTC) Stock Income Statement
NASDAQ:SXTC • VGG2161P1577
2.61 USD
-0.02 (-0.76%)
At close: Feb 13, 2026
2.76 USD
+0.15 (+5.75%)
After Hours: 2/13/2026, 8:00:00 PM
| TTM (2025-9-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.54M | 1.74M | 1.93M | 1.97M | 2.60M | |||
| Cost Of Goods | 1.20M | 1.37M | 1.37M | 1.55M | 1.35M | |||
| Gross Profit | 334.40K | 367.40K | 554.00K | 430.00K | 1.25M | |||
| Operating Expenses | 8.72M | 2.04M | 2.65M | 5.68M | 6.44M | |||
| Research and Development | N/A | 191.40K | N/A | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 8.72M | 1.85M | 2.65M | 5.68M | 6.44M | |||
| Operating Income | -8.38M | -1.67M | -2.09M | -5.26M | -5.19M | |||
| Interest Income/Expense | -497.10K | -648.20K | -544.30K | -480.00K | -40.00K | |||
| Other Income/Expense | 8.30K | 25.10K | -39.00K | 150.00K | -180.00K | |||
| Non Recurring Items | N/A | -1.01M | -422.90K | -350.00K | 0.00 | |||
| Income Before Taxes | -8.87M | -3.30M | -3.10M | -5.93M | -5.41M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | 330.00K | |||
| Net Income | -8.87M | -3.30M | -3.10M | -5.93M | -5.74M | |||
| EBITDA | -8.34M | -1.59M | -1.89M | -5.01M | -4.87M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -161.76 | -348.11 | -4.30K | -26.95K | -191.33K | |||
| Statistics | ||||||||
| Gross Profit Margin | 21.74% | 21.10% | 28.73% | 21.83% | 48.08% | |||
| Profit Margin | -576.72% | -189.77% | -160.67% | -301.02% | -220.77% | |||
| Operating Profit Margin | -544.93% | -96.18% | -108.49% | -267.01% | -199.62% | |||
All data in USD